Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there. Did your doctor somehow miss the recovery protocol that Pedro Bach-y-Rita used to recover fully back in 1958 with only a partial brain?

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label urine. Show all posts
Showing posts with label urine. Show all posts

Saturday, July 27, 2024

Dental pulp stem cells regenerate neural tissue in degenerative disorders and stroke rehabilitation: A scope systematic review

I still prefer handing your competent? doctor a pee cup and asking for stem cells in return.  It has only been 11+ years, where the fuck is your doctor's protocol on turning urine into stem cells?

Turning urine into brain cells could help fight Alzheimer’s, Parkinson’s

December 2012

The latest here:

Dental pulp stem cells regenerate neural tissue in degenerative disorders and stroke rehabilitation: A scope systematic review

Open AccessPublished:July 24, 2024DOI:https://doi.org/10.1016/j.heliyon.2024.e35080
>

Abstract

Background

Dental Pulp Stem Cells (DPSCs) possess a remarkable ability for tissue differentiation, making them highly efficient in tissue regeneration and inflammation regulation. This systematic study proposes to find an answer to the question, "Do DPSCs have the ability to regenerate and rehabilitate nerve tissue?"

Methods

This systematic review was conducted based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria, and the principle of non-bias was respected. All the articles from 2014-2024 were extracted from the Web of Science, PubMed, and Scopus databases. This study extracted the antigens and pro-inflammatory factors associated with DPSCs' involvement and how they affect the CNS's neural tissue regeneration.

Results

Two persons of researchers searched the database. After screening the full texts, they included 11 articles in their study. DPSCs control the following antigens: CD73, CD34, CD90, CD105, CD14, CD45, CD19Oct-4, CD73, CD31, CD34CD29CD44. Even though hematopoietic markers did not change much, OCT-4 and CD-73 were increased by DPSCs. DPSC-derived exosomes suppressed the expression of IL-6, IL-1β, TNF-α, and TGF, key mediators of nerve tissue inflammation. Additionally, DPSCs show high Vascular Endothelial Growth Factor (VEGF) expression in mice brain tissue cultures. DPSCs reduce Subarachnoid Hemorrhage (SAH), a condition in which blood collects in the subarachnoid space and causes ischemia.

Discussion

DPSCs showed the ability to regenerate nerve tissue and brain ganglia, stimulating angiogenesis by expressing cell markers and controlling growth factors in mice, and high therapeutic potential in neurodegenerative disorders. The present study invites further research in neurological disorders, specifically strokes, to prescribe these stem cells to the human population.

Wednesday, April 3, 2024

Stem Cells Spark Hope in Spinal Cord Recovery

What SPECIFIC STROKE LEADER do we talk to to get similar research done for stroke? Oh, I guess there is NO leadership in stroke, you're screwed! 

But your doctor and hospital followed this up, didn't they? NO? So they are completely incompetent?

Turning urine into brain cells could help fight Alzheimer’s, Parkinson’s

December 2012

 

I still prefer handing your doctor a pee cup and asking for stem cells in return.  It has only been 11 years, where the fuck is your doctor's protocol on turning urine into stem cells?

 


Stem Cells Spark Hope in Spinal Cord Recovery

Summary: A phase 1 clinical trial has revealed that stem cells derived from patients’ own fat may safely enhance sensation and movement in individuals with traumatic spinal cord injuries. In the study, seven out of ten adults showed measurable improvements on the ASIA Impairment Scale, experiencing increased sensation, muscle strength, and improved bowel function without serious side effects.

The findings challenge the longstanding belief that spinal cord injuries are irreparable, offering new hope for treatments. With the spinal cord’s limited repair capability, this research signifies a crucial step towards innovative therapies, emphasizing the need for further studies to unlock the full potential of stem cell treatments.

Key Facts:

  1. The trial showed seven participants improved in sensory and motor functions post-stem cell therapy, marking a significant finding in spinal cord injury treatment.
  2. No adverse events were reported, highlighting the safety of using fat-derived stem cells for spinal cord injuries.
  3. The research paves the way for larger, controlled trials to assess the efficacy and optimal patient profiles for stem cell therapy in spinal cord recovery.

Source: Mayo Clinic

A Mayo Clinic study shows stem cells derived from patients’ own fat are safe and may improve sensation and movement after traumatic spinal cord injuries.

The findings from the phase 1 clinical trial appear in Nature Communications.

The results of this early research offer insights on the potential of cell therapy for people living with spinal cord injuries and paralysis for whom options to improve function are extremely limited.

This shows a spine.
Stem cells are used mainly in research in the U.S., and fat-derived stem cell treatment for spinal cord injury is considered experimental by the Food and Drug Administration. Credit: Neuroscience News

In the study of 10 adults, the research team noted seven participants demonstrated improvements based on the American Spinal Injury Association (ASIA) Impairment Scale. Improvements included increased sensation when tested with pinprick and light touch, increased strength in muscle motor groups, and recovery of voluntary anal contraction, which aids in bowel function.

The scale has five levels, ranging from complete loss of function to normal function. The seven participants who improved each moved up at least one level on the ASIA scale. Three patients in the study had no response, meaning they did not improve but did not get worse.

“This study documents the safety and potential benefit of stem cells and regenerative medicine,” says Mohamad Bydon, M.D., a Mayo Clinic neurosurgeon and first author of the study.

“Spinal cord injury is a complex condition. Future research may show whether stem cells in combination with other therapies could be part of a new paradigm of treatment to improve outcomes for patients.”

No serious adverse events were reported after stem cell treatment. The most commonly reported side effects were headache and musculoskeletal pain that resolved with over-the-counter treatment.

In addition to evaluating safety, this phase 1 clinical trial had a secondary outcome of assessing changes in motor and sensory function. The authors note that motor and sensory results are to be interpreted with caution given limits of phase 1 trials. Additional research is underway among a larger group of participants to further assess risks and benefits.

The full data on the 10 patients follows a 2019 case report that highlighted the experience of the first study participant who demonstrated significant improvement in motor and sensory function.

Stem cells’ mechanism of action not fully understood

In the multidisciplinary clinical trial, participants had spinal cord injuries from motor vehicle accidents, falls and other causes. Six had neck injuries; four had back injuries. Participants ranged in age from 18 to 65.

Participants’ stem cells were collected by taking a small amount of fat from a 1- to 2-inch incision in the abdomen or thigh. Over four weeks, the cells were expanded in the laboratory to 100 million cells and then injected into the patients’ lumbar spine in the lower back. Over two years, each study participant was evaluated at Mayo Clinic 10 times.

Although it is understood that stem cells move toward areas of inflammation — in this case the location of the spinal cord injury — the cells’ mechanism of interacting with the spinal cord is not fully understood, Dr. Bydon says.

As part of the study, researchers analyzed changes in participants’ MRIs and cerebrospinal fluid as well as in responses to pain, pressure and other sensation. The investigators are looking for clues to identify injury processes at a cellular level and avenues for potential regeneration and healing.

The spinal cord has limited ability to repair its cells or make new ones. Patients typically experience most of their recovery in the first six to 12 months after injuries occur. Improvement generally stops 12 to 24 months after injury.

One unexpected outcome of the trial was that two patients with cervical spine injuries of the neck received stem cells 22 months after their injuries and improved one level on the ASIA scale after treatment.

Two of three patients with complete injuries of the thoracic spine — meaning they had no feeling or movement below their injury between the base of the neck and mid-back — moved up two ASIA levels after treatment.

Each regained some sensation and some control of movement below the level of injury. Based on researchers’ understanding of traumatic thoracic spinal cord injury, only 5% of people with a complete injury would be expected to regain any feeling or movement.

“In spinal cord injury, even a mild improvement can make a significant difference in that patient’s quality of life,” Dr. Bydon says.

Research continues into stem cells for spinal cord injuries

Stem cells are used mainly in research in the U.S., and fat-derived stem cell treatment for spinal cord injury is considered experimental by the Food and Drug Administration.

Between 250,000 and 500,000 people worldwide suffer a spinal cord injury each year, according to the World Health Organization.

An important next step is assessing the effectiveness of stem cell therapies and subsets of patients who would most benefit, Dr. Bydon says. Research is continuing with a larger, controlled trial that randomly assigns patients to receive either the stem cell treatment or a placebo without stem cells.

“For years, treatment of spinal cord injury has been limited to supportive care, more specifically stabilization surgery and physical therapy,” Dr. Bydon says.

“Many historical textbooks state that this condition does not improve. In recent years, we have seen findings from the medical and scientific community that challenge prior assumptions. This research is a step forward toward the ultimate goal of improving treatments for patients.”

Dr. Bydon is the Charles B. and Ann L. Johnson Professor of Neurosurgery. This research was made possible with support from Leonard A. Lauder, C and A Johnson Family Foundation, The Park Foundation, Sanger Family Foundation, Eileen R.B. and Steve D. Scheel, Schultz Family Foundation, and other generous Mayo Clinic benefactors. The research is funded in part by a Mayo Clinic Transform the Practice grant.

Review the study for a complete list of authors and funding.

About this stem cell and SCI research news

Author: Megan Luihn
Source: Mayo Clinic
Contact: Megan Luihn – Mayo Clinic
Image: The image is credited to Neuroscience News

Thursday, January 13, 2022

‘Put Ya’ Lighters Up’: New Study Finds Cannabis Could Block COVID-19 From Entering The Body

DO NOT DO THIS!  Your doctor would never approve. But at least there is some research for this as compared to drinking your urine. 

Anti-vaxxer tells supporters the new COVID antidote is in 'urine therapy'

There is no scientific or peer-reviewed research to support Key's claims.

The latest here:

 ‘Put Ya’ Lighters Up’: New Study Finds Cannabis Could Block COVID-19 From Entering The Body

Midsection Of Woman Holding Medical Cannabis And Container
Midsection Of Woman Holding Medical Cannabis And Container

Source: Kirill Vasikev / EyeEm / Getty

A new study suggests there may be some special health benefits hidden in cannabis plants that could help to block COVID-19 from entering the body.

Scientists from Oregon State University and Oregon Health & Sciences University published a new peer-review study that examined three cannabis compounds that are found in THC and CBD: cannabigerolic acid, which scientists dubbed CBG-A; tetrahydrocannabinolic acid, known as THC-A; and cannabidiolic acid, or CBD-A.

After extracting them from the plant, the biological compounds were then incubated with the spike protein from COVID-19 (SARS-COV-2 virus) and were injected into human epithelial cells after 24 hours. Scientists discovered that the virus’s cells had been miraculously treated by the CBDA and CBGA compounds. The cells had no trace of the COVID-19 RNA, essentially blocking high concentrations of the virus from entering.

RELATED CONTENT: Blowing Smoke: These Are The Best U.S. Cities To Visit If You’re Looking For A Cannabis Vacay

A technique called “affinity-selection mass spectrometry” was used to assess how the compounds interacted with the spike protein of COVID-19. The same effect occurred when scientists conducted the experiment on alpha and beta strains of the variants found in the U.K. and South Africa.

Researchers said that the evidence could provide a strong case for the compounds to be used to create another preventive measure for protecting against stronger variants of the virus in the future.

“With widespread use of cannabinoids, resistant variants could still arise, but the combination of vaccination and CBDA/CBGA treatment should create a more challenging environment with which SARS-CoV-2 must contend, reducing the likelihood of escape,” officials behind the study explained, according to the Journal of Natural Products.

CBDA and CBGA’s “virus-neutralizing” capabilities are definitely promising, but researchers said the compounds would most likely have to be consumed in the form of a pill or liquid in order for people to truly experience their benefits, and that’s only if the Biden Administration authorizes the use of cannabis for researchers to begin experimenting with other ways of fighting off the disease.

 

Friday, March 12, 2021

Study shows reduction in brain injury after stroke patients were treated with their own stem cells

Why bone marrow?  Urine would be much faster and definitely more interesting.

Turning urine into brain cells could help fight Alzheimer’s, Parkinson’s

December 2012

The most important thing from this seems to be the ability to know what damage was objectively determined in your white matter. That knowledge could then be used to determine objectively what interventions of axon pathfinding and dendritic branching work. Thus being able to create protocols. This is so fucking obvious that stroke leaders should add it to the stroke strategy and thus create research to solve the pathfinding and branching needs.

Study shows reduction in brain injury after stroke patients were treated with their own stem cells

Illustration showing the mechanism of an ischemic stroke. In an ischemic stroke, blood supply to part of the brain is decreased, leading to dysfunction of that area of the brain. Here, a blood clot is the reason for restricted blood flow.

Stroke is the third leading cause of death and serious long-term disability and affects nearly 800,000 Americans a year, with someone in the U.S. suffering a stroke every 40 seconds. Roughly 87% of all strokes are ischemic strokes, meaning that a clot blocks blood flow to the brain. Unfortunately 90% of those who suffer an ischemic stroke also end up suffering from weakness or paralysis to one side of the body.

A study conducted by Muhammad Haque, Ph.D. and Sean Savitz, M.D. at The University of Texas Health Science Center at Houston (UTHealth) found that treating patients with stem cells from their own bone marrow could lead to a reduction in brain injury after a stroke caused by a blood clot.

For this study, there were 37 patients from ages 18 to 80. While all received the standard stroke treatment and rehabilitation follow-up, 17 patients whose strokes were the most severe received a bone marrow stem cell therapy. To measure any improvement, the UTHealth team used 3D brain imaging of the patients obtained from MRI scans. They used these images to compare changes in white matter of those treated with their own bone marrow stem cells to those who were not treated.

White matter is a specific type of tissue in the brain that is critical for motor function because it is responsible for carrying movement-related information to the spinal cord.

Three months after the stroke, the MRI scans of each patient showed the expected decrease after a stroke. However, scans taken 12 months after the stroke occurred showed an improvement on average in the 17 patients who received bone marrow cell therapy.

In a press release from UTHealth, Dr. Haque elaborates on what these results could mean for developing treamtents for stroke patients.

“We envision that future clinical trials might be directed toward identifying white matter protection or repair as an important mechanistic target of efficacy studies and potency assays for bone marrow cell therapies.”

The full results to this study were published in STEM CELLS Translational Medicine.

 

Thursday, March 11, 2021

Abstract 23: Intracerebral Transplantation of Autologous Bone Marrow Stem Cell (BMSC) for Subacute Ischemic Stroke, Phase 1 Clinical Trial (RAINBOW Trial)

 Why choose bone marrow rather than urine? Much much simpler to collect. 20-50 million cells is nothing compared to the 5.5 billion I lost. Doing it 2 months after the stroke means you will have a difficult time distinguishing spontaneous recovery vs. stem cell recovery. 

I still prefer handing your doctor a pee cup and asking for stem cells in return. 

Turning urine into brain cells could help fight Alzheimer’s, Parkinson’s

December 2012 

The latest here:

Abstract 23: Intracerebral Transplantation of Autologous Bone Marrow Stem Cell (BMSC) for Subacute Ischemic Stroke, Phase 1 Clinical Trial (RAINBOW Trial)

 
Originally publishedhttps://doi.org/10.1161/str.52.suppl_1.23Stroke. 2021;52:A23

Background: Recent breakthrough in cell therapy is expected to reverse the neurological sequelae of stroke. We investigated the safety and feasibility of intracerebral transplantation of autologous BMSC in the subacute phase of stroke (RAINBOW trial). Several new aspects including cell labeling and tracking, socioecomonic analysis using QALY, and the use of human platelet lysate instead of fetal bovine serum were adopted. (UNIN ID: UMIN000026130)

Methods/Design: This is a phase 1, open-label, uncontrolled, dose-response study enrolling adults with severe motor deficits (mRS>3) 14 days after stroke. Approximately 50 mL of the bone marrow is extracted from the iliac bone of each patient 15 days or later from the onset, and BMSCs are cultured with allogeneic human platelet lysate (PL) and are labeled with superparamagnetic iron oxide for cell tracking using MRI. BMSCs are stereotactically administered around the area of infarction approximately 2 months from the ischemic stroke. Each patient will be administered a dose of 20 or 50 million cells. Neurological scoring, MRI for cell tracking, 18F-fuorodeoxyglucose positron emission tomography, and 123I-Iomazenil single photon emission computed tomography will be performed throughout 1 year after the administration.

Results: All 7 patients have been successfully finished transplantation, and there was no severe adverse event in any of the patient regarding the surgical procedure nor cell quality. Favorable motor recoveries (change in mRS > 1) are seen in 5 of 7 patients, and cell engraftment and migration to ischemic site was also observed.

Discussion: This is a first-in-human trial to use labelled BMSC to the patients with subacute ischemic stroke. Intracerebral transplantation of autologous BMSC is safe and well tolerated. Cell migration to the ischemic boundary can clarify the therapeutic mechanisms.

Monday, May 18, 2020

Repairing stroke-damaged rat brains

Now YOU just need to insist that your incompetent doctors and stroke hospitals  get human testing going.  Or YOU get every leader in that stroke hospital fired starting with the board of directors.   

I still prefer handing your doctor a pee cup and asking for stem cells in return.  It has only been 8 years, where the fuck is your doctor's protocol on turning urine into stem cells?

Turning urine into brain cells could help fight Alzheimer’s, Parkinson’s

December 2012

Oops, I'm not playing by the polite rules of Dale Carnegie,  'How to Win Friends and Influence People'. 

Politeness will never solve anything in stroke. Yes, I'm a bomb thrower and proud of it. Someday a stroke "leader" will ream me out for being truthful by making them look bad, I look forward to that day. 

The latest here:

Repairing stroke-damaged rat brains

Date:
April 8, 2020
Source:
Lund University
Summary:
Researchers have succeeded in restoring mobility and sensation of touch in stroke-afflicted rats by reprogramming human skin cells to become nerve cells, which were then transplanted into the rats' brains.
Share:
FULL STORY

Stroke in brain concept illustration (stock image). | Credit: © peterschreiber.media / stock.adobe.com
Stroke in brain concept illustration (stock image).
Credit: © peterschreiber.media / Adobe Stock
Researchers at Lund University in Sweden have succeeded in restoring mobility and sensation of touch in stroke-afflicted rats by reprogramming human skin cells to become nerve cells, which were then transplanted into the rats' brains. The study has now been published in the Proceedings of the National Academy of Sciences (PNAS).
"Six months after the transplantation, we could see how the new cells had repaired the damage that a stroke had caused in the rats' brains," says Professor Zaal Kokaia, who together with senior professor Olle Lindvall and researcher Sara Palma-Tortosa at the Division of Neurology is behind the study.
Several previous studies from the Lund team and others have shown that it is possible to transplant nerve cells derived from human stem cells or from reprogrammed cells into brains of rats afflicted by stroke. However, it was not known whether the transplanted cells can form connections correctly in the rat brain in a way that restores normal movement and feeling.
"We have used tracking techniques, electron microscopy and other methods, such as light to switch off activity in the transplanted cells, as a way to show that they really have connected correctly in the damaged nerve circuits. We have been able to see that the fibres from the transplanted cells have grown to the other side of the brain, the side where we did not transplant any cells, and created connections. No previous study has shown this," says Zaal Kokaia, who, even though he and colleague Olle Lindvall have studied the brain for several decades, is surprised by the results.
"It is remarkable to find that it is actually possible to repair a stroke-damaged brain and recreate nerve connections that have been lost. The study kindles hope that in the future it could be possible to replace dead nerve cells with new healthy nerve cells also in stroke patients, even though there is a long way to go before achieving that," says Olle Lindvall.
The researchers have used human skin cells that have been reprogrammed in the laboratory to become nerve cells. They were then transplanted into the cerebral cortex of rats, in the part of the brain that is most often damaged after a stroke. Now the researchers will undertake further studies.
"We want to know more about how the transplanted cells affect the opposite hemisphere of the brain. We also want to take a closer look at how a transplant affects intellectual functions such as memory. In addition, we will study possible side effects. Safety is, of course, extremely important for cell transplantation if it is going to be used clinically in the future," says Zaal Kokaia.

Story Source:
Materials provided by Lund University. Note: Content may be edited for style and length.

Journal Reference:
  1. Sara Palma-Tortosa, Daniel Tornero, Marita Grønning Hansen, Emanuela Monni, Mazin Hajy, Sopiko Kartsivadze, Sibel Aktay, Oleg Tsupykov, Malin Parmar, Karl Deisseroth, Galyna Skibo, Olle Lindvall, Zaal Kokaia. Activity in grafted human iPS cell–derived cortical neurons integrated in stroke-injured rat brain regulates motor behavior. Proceedings of the National Academy of Sciences, 2020; 202000690 DOI: 10.1073/pnas.2000690117

Cite This Page:
Lund University. "Repairing stroke-damaged rat brains." ScienceDaily. ScienceDaily, 8 April 2020. www.sciencedaily.com/releases/2020/04/200408102150.htm.

Saturday, May 11, 2019

Using Dental Pulp Stem Cells for Stroke Therapy

I still prefer handing your doctor a pee cup and asking for stem cells in return. 

Turning urine into brain cells could help fight Alzheimer’s, Parkinson’s

December 2012

 

Did this from August 2016 provide any answers?  Did you even know about it? 

TOOTH (The Open study Of dental pulp stem cell Therapy in Humans): Study protocol for evaluating safety and feasibility of autologous human adult dental pulp stem cell therapy in patients with chronic disability after stroke

The latest here:

Using Dental Pulp Stem Cells for Stroke Therapy


Maria R. Gancheva1*, Karlea L. Kremer1, Stan Gronthos2,3 and Simon A. Koblar1,3,4
  • 1Stroke Research Programme Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia
  •  3South Australian Health and Medical Research Institute, Adelaide, SA, Australia
  • 4Central Adelaide Local Health Network, Adelaide, SA, Australia
Stroke is a leading cause of permanent disability world-wide, but aside from rehabilitation, there is currently no clinically-proven pharmaceutical or biological agent to improve neurological disability. Cell-based therapies using stem cells, such as dental pulp stem cells, are a promising alternative for treatment of neurological diseases, including stroke. The ischaemic environment in stroke affects multiple cell populations, thus stem cells, which act through cellular and molecular mechanisms, are promising candidates. The most common stem cell population studied in the neurological setting has been mesenchymal stem cells due to their accessibility. However, it is believed that neural stem cells, the resident stem cell of the adult brain, would be most appropriate for brain repair. Using reprogramming strategies, alternative sources of neural stem and progenitor cells have been explored. We postulate that a cell of closer origin to the neural lineage would be a promising candidate for reprogramming and modification towards a neural stem or progenitor cell. One such candidate population is dental pulp stem cells, which reside in the root canal of teeth. This review will focus on the neural potential of dental pulp stem cells and their investigations in the stroke setting to date, and include an overview on the use of different sources of neural stem cells in preclinical studies and clinical trials of stroke.

Introduction

The central nervous system (CNS) functions through complex molecular and cellular interactions, and disruption by severe injury or disease leads to irreversible neuronal loss and associated functional deficits. This results in highly debilitating pathologies associated with significant health and economic burden for patients, their families, carers, and the health systems.
Stroke is a global health care problem and a leading cause of acquired adult neurological disability (1). With an aging population, the incidence and prevalence of stroke is predicted to rise. A stroke is characterised by reduced and insufficient blood supply to part of the brain. Inadequate oxygen and nutrients lead to tissue infarction, resulting in disability due to loss-of-function associated with the damaged area of the brain.
There are two main types of stroke; haemorrhagic and ischaemic. Haemorrhagic strokes, accounting for 13 percent of strokes (1), result from bleeding when a blood vessel is ruptured. Ischaemic stroke is the most common presentation of stroke at 87 percent of all cases (1), and is due to an obstruction in the blood supply, which could be formed locally (thrombosis) or formed elsewhere in the body (embolism).
During an ischaemic stroke, a complex chain of events takes place at the molecular and cellular levels, which results in cell necrosis at the site of the vascular insult (the ischaemic core), while the region surrounding the core (the ischaemic penumbra) remains viable for some time due to collateral blood supply and can thus be salvaged. A strong inflammatory response is initiated within hours of stroke onset, characterised by reactive astrogliosis, microglial activation, disruption to the blood-brain barrier (BBB), and infiltration of neutrophils and monocytes/macrophages (2). Growth factors and inflammatory mediators, from local glial and inflammatory cells, alter the reaction of endogenous neural stem and progenitor cells. Over time, reorganisation of the neural network around the core takes place. If untreated, the penumbra will transform into ischaemic tissue, expanding the irreversibly damaged area of brain. There is an opportunity to save the penumbral tissue via acute recanalisation therapies.
The currently available therapeutic interventions, such as thrombectomy and thrombolysis, are limited to a narrow therapeutic window and eligibility criteria, and though they have a significant impact on stroke outcome, disability remains after any intervention. Thrombectomy refers to the mechanical removal of a blood clot, which has been effective when performed within 24 h post-stroke (3). The more common intervention is thrombolysis by intravenously administered recombinant tissue plasminogen activator, to breakdown the clot. This is currently the only approved pharmacological agent that shows significant benefits in acute ischaemic stroke, but is only applicable within a short time frame of 4.5 h from symptomatic onset (4). Unfortunately, many patients are ineligible for these reperfusion therapies. In addition, poor patient outcomes can still be observed. Once a stroke patient is stabilised, rehabilitation interventions are relied upon to promote neuroplasticity, as patients adapt to residual disability. Improvements are most significant in the first several months following a stroke (5). There is currently no therapy that can restore damaged neural tissue and its associated functions.
Cell-based therapies have the potential to promote functional recovery in patients affected by stroke and other neurological diseases. Stem cells are promising candidates, as they can act through multiple cellular and molecular mechanisms to provide support for endogenous cells, stimulate endogenous processes, and act as a source of cell replacement. Neural stem cells (NSC), which reside in specific areas of the CNS, are the most appropriate stem cells for brain repair. Research is focused on two therapeutic paradigms; enhancing and manipulating endogenous NSC, and implanting exogenous NSC. Reprogramming strategies are being applied to develop NSC from more easily accessible and abundant cell types (6). Dental pulp stem cells (DPSC) are adult stem cells obtained from the dental pulp tissue in the tooth chamber (7). These cells are easily sourced and have neurogenic potential. They are being investigated as an alternative source of neural cells and in preclinical models of neurological diseases, including stroke. This review will focus on the potential use of human DPSC for stroke therapy and will include an overview of different types of NSC being studied.

Monday, October 16, 2017

Fat Cells Converted Into Stem Cells Can Repair Any Damaged Tissues

Personally I still think handing your doctor a pee cup and asking for stem cells is much better, but to each her own.  Or course stem cells are probably decades off before becoming useful in stroke.

Turning urine into brain cells could help fight Alzheimer’s, Parkinson’s and it is only 5 years old, plenty of time for your doctor to contact researchers and get something done. But I bet absolutely NOTHING was done by your doctor, incompetence in action once again.

Fat Cells Converted Into Stem Cells Can Repair Any Damaged Tissues

Stem cell therapies capable of regenerating any human tissue damaged by injury, disease or ageing could be available within a few years, following landmark research led by UNSW Australia researchers. Watch the video below for more details.
The repair system, similar to the method used by salamanders to regenerate limbs, could be used to repair everything from spinal discs to bone fractures, and has the potential to transform current treatment approaches to regenerative medicine. The findings were published in the Proceedings of the National Academy of Sciences journal.
“This technique is a significant advance on many of the current unproven stem cell therapies, which have shown little or no objective evidence they contribute directly to new tissue formation,” study lead author, haematologist and UNSW Associate Professor John Pimanda said.
The technique developed by UNSW researchers involves extracting adult human fat cells and treating them with the compound 5-Azacytidine (AZA), along with platelet-derived growth factor-AB (PDGF-AB) for approximately two days. The cells are then treated with the growth factor alone for a further two-three weeks.
AZA is known to induce cell plasticity, which is crucial for reprogramming cells. The AZA compound relaxes the hard-wiring of the cell, which is expanded by the growth factor, transforming the bone and fat cells into iMS cells. When the stem cells are inserted into the damaged tissue site, they multiply, promoting growth and healing.
The technique is similar to salamander limb regeneration, which is also dependent on the plasticity of differentiated cells, which can repair multiple tissue types, depending on which body part needs replacing.
Along with confirming that human adult fat cells reprogrammed into iMS stem cells can safely repair damaged tissue in mice, the researchers said further work is required to establish whether iMS cells remain dormant at the sites of transplantation and retain their capacity to proliferate on demand.
“We are currently assessing whether adult human fat cells reprogrammed into iMS cells can safely repair damaged tissue in mice, with human trials expected to begin in late 2017.” Associate Professor Pimanda said.

Monday, January 16, 2017

New urine test can quickly detect whether a person has a healthy diet

This won't do you any good since your doctor never setup a stroke diet protocol s/he won't want a test proving that your diet is bad.  And just maybe you want to test for blood clots.

Nanotechnology urine test could detect deadly blood clots

After you pee into the cup ask your doctor for stem cells back.

Turning urine into brain cells could help fight Alzheimer’s, Parkinson’s

New urine test can quickly detect whether a person has a healthy diet


Imperial College London Health News
Scientists have developed a urine test that measures the health of a person's diet.

The five–minute test measures biological markers in urine created by the breakdown of foods such as red meat, chicken, fish and fruit and vegetables.

The analysis, developed by researchers from Imperial College London, Newcastle University and Aberystwyth University, also gives an indication of how much fat, sugar, fibre and protein a person has eaten.

Although the work is at an early stage, the team hope that with future development the test will be able to track patients' diets. It could even be used in weight loss programmes to monitor food intake.

Evidence suggests people inaccurately record their own diets, and under–report unhealthy food while over–reporting fruit and vegetable intake – and that the likelihood of inaccuracies in food diaries increases if a person is overweight or obese.

Professor Gary Frost, senior author of the study from the Department of Medicine at Imperial said: "A major weakness in all nutrition and diet studies is that we have no true measure of what people eat. We rely solely on people keeping logs of their daily diets – but studies suggest around 60 per cent of people misreport what they eat to some extent. This test could be the first independent indicator of the quality of a person's diet – and what they are really eating."

In study, published in the journal Lancet Diabetes and Endocrinology and conducted at the MRC–NIHR National Phenome Centre, the researchers asked 19 volunteers to follow four different diets, ranging from very healthy to very unhealthy. These were formulated using World Health Organisation dietary guidelines, which advise on the best diets to prevent conditions such as obesity, diabetes and heart disease.

The volunteers strictly followed these diets for three days while in a London research facility, throughout which the scientists collected urine samples in the morning, afternoon and evening.

The research team then assessed the urine for hundreds of compounds, called metabolites, produced when certain foods are broken down in the body.

These included compounds that indicate red meat, chicken, fish, fruit and vegetables, as well as giving a picture of the amount of protein, fat, fibre and sugar eaten. They also included compounds that point to specific foods such as citrus fruits, grapes and green leafy vegetables.

From this information the researchers were able to develop a urine metabolite profile that indicated a healthy, balanced diet with a good intake of fruit and vegetables. The idea is this 'healthy diet' profile could be compared to the diet profile from an individual's urine, to provide an instant indicator of whether they are eating healthily.

The scientists then tested the accuracy of the test on data from a previous study. This included 225 UK volunteers as well as 66 people from Denmark. All of the volunteers had provided urine samples, and kept information on their daily diets.

Analysis of these urine samples enabled the researchers in the current study to accurately predict the diet of the 291 volunteers.

Thursday, December 15, 2016

Protein in Urine Linked to Increased Risk of Memory Problems, Dementia

Your doctor should be taking a sample to baseline your status post-stroke because of your likely onset of dementia.

1. A documented 33% dementia chance post-stroke from an Australian study   May 2012.
2. Then this study came out and seems to have a range from 17-66%. December 2013.
3. A 20% chance in this research.   July 2013.

I probably wouldn't take this sample to your doctor to get stem cells made. 

Turning urine into brain cells could help fight Alzheimer’s, Parkinson’s

The latest here:

Protein in Urine Linked to Increased Risk of Memory Problems, Dementia 

People who have protein in their urine are more likely to later develop problems with thinking and memory skills or even dementia, according to a meta-analysis published in the December 14, 2016, online issue of Neurology.
The researchers looked at all available studies on kidney problems and the development of cognitive impairment or dementia.
“Kidney dysfunction has been considered a possible risk factor for cognitive impairment or dementia,” said Kay Deckers, MD, Maastricht University, Maastricht, the Netherlands. “Chronic kidney disease and dementia share many risk factors, such as high blood pressure, diabetes, and high cholesterol, and both show similar effects on the brain, so they may have shared vascular factors or there may even be a direct effect on the brain from kidney problems.”
A total of 22 studies on the topic were included in the systematic review. Five of the studies, including 27,805 people, were evaluated in the meta-analysis on albuminuria or proteinuria.
The analysis showed that people with protein in the urine were 35% more likely to develop cognitive impairment or dementia than people who did not have protein in their urine.
For another marker of kidney function, estimated glomerular filtration rate, the results were mixed and did not show an association. For 3 other markers of kidney function, cystatin C, serum creatinine, and creatinine clearance, no meta-analysis could be completed because the few studies available did not use the same methods and could not be compared.
“Protein in the urine was associated with a modestly increased risk of cognitive impairment or dementia,” said Dr. Deckers. “More research is needed to determine whether the kidney problems are a cause of the cognitive problems or if they are both caused by the same mechanisms.”
SOURCE: American Academy of Neurology

Friday, October 18, 2013

Nanotechnology urine test could detect deadly blood clots

So who is going to translate this into  a actual test usable in doctor offices and hospitals?  Damnable lazy stroke associations, you know who you are. Why don't you ever write on survivor blogs telling us what you are doing for survivors?

Nanotechnology urine test could detect deadly blood clots

The abstract this is based on here;

Nanoparticles That Sense Thrombin Activity As Synthetic Urinary Biomarkers of Thrombosis

Thrombin is a serine protease and regulator of hemostasis that plays a critical role in the formation of obstructive blood clots, or thrombosis, that is a life-threatening condition associated with numerous diseases such as atherosclerosis and stroke. ... Using a thromboplastin-induced mouse model of pulmonary embolism, we show that urinary biomarker levels differentiate between healthy and thrombotic states and correlate closely with the aggregate burden of clots formed in the lungs. ... Here we hypothesized that synthetic biomarkers could be tailored to survey intravascular sites for acute thrombosis, the activation of a cascade of protease activity that orchestrates the formation of obstructive blood clots within vessels (Figure 1A)

Monday, May 20, 2013

American Stroke Association launches app to ID symptoms

Lazy, lazy, lazy.  Expecting the general public to subjectively diagnose a stroke. If they were any good they would have an app that checks the urine, does a blood test, EEG Headset, or Pupil response via infrared light

American Stroke Association launches app to ID symptoms

The app is part of a longtime, broader campaign to spread awareness about how to identify a stroke: The newest iteration of the campaign includes an infographic and an online video PSA.

Once again proving they are just a press release organization.

Thursday, May 9, 2013

Spot a Stroke F.A.S.T. - android app

I told you you would get these feel good notifications during this month. This is the AHA/ASAs attempt to be relevant.Now to make it an objective diagnosis they would need to add a urine detector/analyzer to it. I can just see you walking up to a possible stroke and asking them to pee over this sensor. It still would be better than the subjective diagnosis that goes on today. We're in the 21st century and we still don't have anything objective. What has the WSO and stroke associations been doing for the past 40 years. Nothing?

Spot a Stroke F.A.S.T. - android app

Doesn't anyone at the ASA/WSO keep track of news/research about stroke? They do have stroke in their name.

Tuesday, December 11, 2012

Turning urine into brain cells could help fight Alzheimer’s, Parkinson’s

Go up to your doctor and with a straight face ask him/her when your urine can be turned into brain cells. Come on, Do it.  It should be possible to help us strokies with this.

Walk up to your doctor with your specimen cup and ask for brain cells in return.  You may have to wait 50 years but start now.

Turning urine into brain cells could help fight Alzheimer’s, Parkinson’s

Turning urine into brain cells